A long-term study of olipudase alfa in patients with acid sphingomyelinase deficiency

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-000051-40

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to obtain data regarding the safety of olipudase alfa in patients with acid sphingomyelinase deficiency (ASMD) who are exposed to long-term treatment with olipudase alfa


Critère d'inclusion

  • Patients with acid sphingomyelinase deficiency (Niemann-Pick Type B disease)

Liens